Caroline A. Nebhan
Hematology | Oncology
5171 South Cottonwood Street
Suite 610
Murray, UT 84107
Suite 610
Murray, UT 84107
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 29 publications
Tumor Immunophenotypic Correlates in Patients Aged 80 Years or Older With Non-Small Cell Lung Cancer and Outcomes to First-Line Pembrolizumab in PD-L1 High (≥50%) Patients.
Journal: Clinical lung cancer
Published: December 04, 2024
Corrigendum to 'Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States' [Clinical Lymphoma, Myeloma, and Leukemia Volume 24, Issue 8, August 2024, Pages 523-530].
Journal: Clinical lymphoma, myeloma & leukemia
Published: November 27, 2024
Safety and efficacy outcomes of early cessation of anti-PD1 therapy in patients 80 years or older: A retrospective cohort study.
Journal: Cancer letters
Published: March 15, 2024
Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States.
Journal: Clinical lymphoma, myeloma & leukemia
Published: January 09, 2024
Metastatic Penile Squamous Cell Carcinoma Responsive to Enfortumab Vedotin.
Journal: International journal of molecular sciences
Published: October 07, 2023
Characterization of Age-Associated, Neutrophil-to-Lymphocyte Ratio (NLR) and Systemic Immune-Inflammatory Index (SII) as Biomarkers of Inflammation in Geriatric Patients with Cancer Treated with Immune Checkpoint Inhibitors: Impact on Efficacy and Survival.
Journal: Cancers
Published: September 18, 2023
Generation of Orthotopic Patient-Derived Xenografts in Humanized Mice for Evaluation of Emerging Targeted Therapies and Immunotherapy Combinations for Melanoma.
Journal: Cancers
Published: June 01, 2023
Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: May 16, 2023
Immune Checkpoint Inhibitors: The Unexplored Landscape of Geriatric Oncology.
Journal: The oncologist
Published: February 14, 2022
Clinical Models to Define Response and Survival With Anti-PD-1 Antibodies Alone or Combined With Ipilimumab in Metastatic Melanoma.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: February 10, 2022
Patient Harassment of Medical Trainees: Reflections for a More Inclusive Future.
Journal: JAMA oncology
Published: February 03, 2022
Last Updated: 09/26/2026